1st October 2013
Polar Capital Global Healthcare Growth and Income Trust plc (the "Company")
Top Ten Equity Holdings - 30th September 2013
Polar Capital Global Healthcare Growth and Income Trust plc is pleased to announce that as at 30th September 2013 the top ten equity holdings and the sector breakdown were as follows:
Top 10 Holdings |
% |
Novartis |
7.3% |
Eli Lilly |
7.0% |
Merck & Co |
6.6% |
AstraZeneca |
6.2% |
Roche Holding |
5.9% |
Pfizer |
5.7% |
GlaxoSmithKline |
5.6% |
Sanofi |
4.9% |
Johnson & Johnson |
3.4% |
Astellas Pharma |
3.4% |
Total |
56.0% |
Sector Exposure |
% |
Pharmaceuticals |
68.6% |
Health Care Equipment |
6.2% |
Specialized REITs |
5.6% |
Biotechnology |
4.7% |
Health Care Facilities |
4.3% |
Health Care Services |
3.1% |
Health Care Supplies |
2.0% |
Health Care Technology |
1.5% |
Life Sciences Tools & Services |
1.3% |
Health Care Distributors |
1.0% |
Managed Health Care |
0.6% |
Drug Retail |
0.5% |
Life & Health Insurance |
0.4% |
Cash |
0.3% |
Multi-line Insurance |
0.1% |
Total |
100.0% |
A copy of the entire portfolio as at 30th of August 2013 will be available to view shortly on the Company's website.
The monthly factsheet will usually be available on the Company's website on the 10th working day after the month end and includes a commentary by the investment manager. www.Polarcapitalhealthcaretrust.com
Neither the contents of the Company's website nor the contents of any website accessible from the hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this announcement.